Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Inventory" stands at 305.69 Billion Japanese Yens as of 06/30/2025, the highest value at least since 12/31/2010, the period currently displayed.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Inventory" stands at 305.69 Billion JPY. This represents an increase of 2.84 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.39 percent compared to the value the year prior.
The 1 year change in percent is 19.39.
The 3 year change in percent is 85.46.
The 5 year change in percent is 97.13.
The 10 year change in percent is 93.86.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Inventory | 905,699,262,464.00 |
![]() | Johnson & Johnson - Inventory | 486,508,953,600.00 |
![]() | AbbVie Inc - Inventory | 399,570,305,024.00 |
![]() | Roche Holding AG - Inventory | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Inventory | 280,205,508,085.11 |